User profiles for A. Cancellieri

Adriano Cancellieri

Universitą degli Studi Milano-Bicocca
Verified email at unimib.it
Cited by 538

[BOOK][B] Hotel House. Etnografia di un condominio multietnico

A Cancellieri - 2013 - boa.unimib.it
L’Hotel House č un enorme condominio di architettura razionalista composto da 480
appartamenti, situato nella parte meridionale della cittadina di Porto Recanati, nel Sud delle …

Thoracic endometriosis: current knowledge

M Alifano, R Trisolini, A Cancellieri… - The Annals of thoracic …, 2006 - Elsevier
Thoracic endometriosis syndrome includes four well-recognized clinical entities, namely
catamenial pneumothorax, catamenial hemothorax, catamenial hemoptysis and lung nodules, …

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations

…, G Mazzaglia, N Luxi, A Cancellieri… - Expert review of …, 2020 - Taylor & Francis
Introduction Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome
coronavirus (SARS-CoV-2), has quickly spread around the world. Areas covered This …

Adenocarcinoma classification: Pattern and prognosis

E Kuhn, P Morbini, A Cancellieri, S Damiani… - Pathologica, 2018 - cris.unibo.it
Lung cancer is the most frequent human malignancy and the principal cause of cancer-related
death worldwide. Adenocarcinoma is now the main histologic type, accounting for almost …

Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis

…, M Bertaso, A Scarpa, B Murer, A Cancellieri… - The American journal of …, 2003 - Elsevier
To investigate the molecular events that may underpin dysfunctional repair processes that
characterize idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP), we analyzed …

Akt phosphorylation and gefitinib efficacy in patients with advanced non–small-cell lung cancer

…, V Gregorc, C Ligorio, A Cancellieri… - Journal of the …, 2004 - academic.oup.com
Background: Gefitinib, a specific epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitor, has activity against approximately 10% of unselected non–small-cell lung cancer (…

[PDF][PDF] Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization–positive/phospho-Akt–positive or never smoker patients with …

…, G Finocchiaro, S Bartolini, A Cancellieri… - Journal of Clinical …, 2007 - Citeseer
Purpose In non–small-cell lung cancer (NSCLC), clinical and biologic predictors for epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitor sensitivity have been identified in …

Poor concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in the diagnosis of diffuse interstitial lung diseases

…, AS Gamez, JP Mallet, I Serre, A Cancellieri… - American journal of …, 2019 - atsjournals.org
Rationale: The diagnostic concordance between transbronchial lung cryobiopsy (TBLC)—versus
surgical lung biopsy (SLB) as the current gold standard—in interstitial lung disease (ILD…

[HTML][HTML] Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of ΔN-p63

…, V Poletti, B Murer, M Lestani, A Cancellieri… - Laboratory …, 2002 - Elsevier
Products of the p63 gene, a recently described member of the p53 family, are constitutively
expressed in the basal cells of human bronchi and bronchioli. The truncated isoforms of the …

Gefitinib in pretreated non–small-cell lung cancer (NSCLC): Analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally …

…, V Gregorc, E Rossi, A Cancellieri… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To evaluate the correlation between HER2 expression and gefitinib (ZD 1839,
Iressa; AstraZeneca, London, United Kingdom) efficacy in terms of response rate, time to …